Depakote Hair Loss: Risk, Timeline & Fixes

Last updated How we write and review our guides

If your hair started coming out in larger amounts a few months after you began Depakote (divalproex sodium, a form of valproate), you are asking a reasonable question. Alopecia is not a rare footnote for this drug: the current US label lists it among the most common adverse reactions in its highlights, and the UK product information classes it as “common.”[1][6] The good news in the same sources is that the loss is usually diffuse, does not scar, and is generally described as reversible. This page lays out the actual numbers, the usual timing, what is and is not known about dose, and how to handle it without stopping a medication you may need.

Medical note: This article is for general education and does not provide personal medical advice. Do not stop or change Depakote/valproate without medical guidance: the label warns that antiepileptic drugs should not be stopped abruptly.[1] If you're not sure whether you're seeing shedding or breakage, start here: Shedding vs Breakage. If the diagnosis is unclear, start here: How Hair Loss Is Diagnosed. If you have scalp pain/burning, pustules/crusting, heavy scale, open sores, or rapid worsening, start here: When to See a Doctor.

Depakote hair loss: alopecia risk numbers, TE timeline, dose/level factors, labs to consider, and practical steps.
Depakote/valproate is a known trigger for diffuse, non-scarring shedding in some patients. Timing and dose exposure are key clues.

Key points

  • The label figures depend on the condition studied. Alopecia was reported by 7% on Depakote vs 1% on placebo in the migraine trials, 6% vs 1% in an add-on epilepsy trial, and 24% (high dose) vs 13% (low dose) in an epilepsy monotherapy trial.[1]
  • Timing is delayed. Hair loss most often starts about 3 to 6 months after the drug is started.[3] Telogen effluvium, in general, is noticed 2 to 4 months after its trigger.[4]
  • Pattern: diffuse and non-scarring, usually telogen-effluvium-like, and described as usually reversible.[3] If thinning persists after shedding slows, consider an overlap with pattern hair loss.
  • Dose evidence is mixed. Some sources describe it as dose-related; a pooled analysis found no dose or duration effect.[1][6][7]
  • No supplement is proven. Zinc, selenium and biotin are discussed in case reports and mechanism theories only. Talk to your prescriber first.[3]
  • Don't self-stop. Discuss dose, alternatives, and risk/benefit with the prescriber.
  • Related on this site: Medication-Related Shedding • Telogen Effluvium • Blood Tests & Workup.

Quick navigation

How common is Depakote hair loss? (FDA numbers)

The US prescribing information for Depakote (revised March 2026) reports alopecia in several trial sets. The percentages are not interchangeable, because each comes from a different condition, dose, and study design:[1]

  • Migraine prevention trials: 7% with Depakote vs 1% with placebo (202 vs 81 patients).
  • Add-on therapy for complex partial seizures: 6% vs 1% (77 vs 70 patients). Patients were also taking other seizure medicines, so the label notes it is often not possible to attribute a reaction to Depakote alone.
  • Epilepsy monotherapy, high vs low dose: 24% vs 13% (131 vs 134 patients). The mean total valproate concentrations were about 123 and 71 mcg/mL in the two groups.
  • Mania trials: alopecia appears only in a list of reactions reported by more than 1% but not more than 5% of patients, without an exact percentage.

In the migraine study’s long-term extension, alopecia (6%) was the most common primary reason patients stopped the drug.[1] A 2023 narrative review puts the reported range for valproate alopecia at 0.5% to 24% across studies.[3] A pooled analysis of 25 prospective studies estimated an overall incidence of about 11%.[7] These trials were relatively short, so they may not reflect long-term real-world rates, and none of these numbers predicts what will happen to you personally.

Timeline: when shedding starts, peaks, and improves

  • Onset: the 2023 review states that hair loss most commonly occurs three to six months after valproate is introduced.[3] StatPearls likewise lists alopecia among the common effects that usually occur at the start of treatment or after dosage changes.[2] That fits the general telogen effluvium timing: DermNet notes increased hair fall is noticed 2 to 4 months after the triggering event, and the British Association of Dermatologists says it can occur around 3 months after a trigger, including starting a new medication.[4][5]
  • Duration: telogen effluvium shedding typically lasts about 3 to 6 months, and DermNet describes it tapering to normal over 6 to 9 months in most cases.[4][5] The BAD notes it can take many months for hair to return to normal volume.
  • Recovery: the UK product information says regrowth normally begins within six months.[6] The 2023 review describes the loss as typically incomplete and usually reversible, and says regrowth within three months of stopping a causative drug can support the diagnosis.[3] The sources do not give a reliable timeline for people who stay on the drug.

For the general pattern, see Telogen Effluvium.

Pattern clues: TE vs AGA vs patchy loss

Most consistent with medication-triggered TE

  • Diffuse shedding (overall density drop; more hair on the pillow, in the shower, or on the brush).
  • A scalp that looks mostly normal (no heavy crusting or pustules; no shiny scar-like areas).[3]

When to reset the diagnosis

  • Persistent part/crown emphasis after shedding slows: consider TE with pattern hair loss. TE vs Androgenetic Alopecia.
  • Smooth patchy bald spots: consider alopecia areata. Alopecia Areata Hub.
  • Lots of short snapped hairs: breakage rather than shedding. Shedding vs Breakage.
  • Facial or chin hair growth, irregular periods, or acne alongside hair loss: valproate labeling lists hirsutism and hyperandrogenism among reported effects, and the UK information also lists male pattern alopecia under hyperandrogenism.[1][6] This needs medical review, since it is a different pattern from simple shedding. See PCOS Hair Loss & Hormone Tests.

Dose/level factors (what evidence suggests)

The evidence on dose is mixed, and it is better to say so than to quote a threshold:

  • The label’s epilepsy monotherapy trial found alopecia in 24% of the high-dose group vs 13% of the low-dose group, with higher blood levels in the high-dose group.[1]
  • The UK product information describes the alopecia as “transient and/or dose related.”[6]
  • On the other hand, a 2019 meta-analysis concluded that the risk did not depend on dose or treatment time.[7]

The sources I reviewed do not give reliable evidence on what counts as a “high” daily dose in milligrams, whether going from, for example, 500 mg to 1,000 mg changes the odds, whether extended-release differs from delayed-release, or whether long-term use makes the loss permanent. Any dose change is a prescriber decision.

Why it happens (plausible mechanisms)

  • Hair-cycle shift (TE): the drug acts as a trigger that pushes more follicles into the resting (telogen) phase, and the shedding becomes noticeable months later. The 2023 review describes telogen effluvium as the most common type of hair loss seen with antiseizure medicines.[3]
  • Micronutrient theories: the same review discusses biotin, zinc, selenium and vitamin D. In animal models valproate has been shown to induce zinc and selenium deficiencies, but human data are weak: the zinc/selenium supplementation it mentions traces to a single case report.[3] Treat this as a hypothesis, not a proven cause.
  • Hormonal effects: endocrine effects such as hyperandrogenism are listed in labeling and can affect hair in some people.[1][6]

When labs matter (targeted workup)

Not everyone needs lab work. Testing matters more if shedding is heavy, persistent, recurrent, or symptoms suggest another contributor. The BAD notes a blood test may check for other causes such as thyroid conditions and iron deficiency.[5] Valproate levels and routine safety labs (liver tests, blood counts) are managed by your prescriber and are separate from the hair workup.[1] Use the structured page:

What to do (practical plan)

  1. Build a timeline: when did Depakote start or the dose change, and when did shedding become noticeable?
  2. Confirm the pattern: TE vs breakage vs overlapping pattern hair loss.
  3. Talk to the prescriber: if Depakote is suspected, discuss risk and benefit, alternatives, or dose adjustment. The Medication Guide says not to stop Depakote without first talking to a healthcare provider, and the UK information says discontinuation should be gradual under specialist supervision.[1][6]
  4. Be cautious with supplements: no controlled trial shows that zinc, selenium, biotin, L-carnitine or multivitamins prevent or reverse valproate hair loss.[3] They also carry limits: the adult upper intake level is 40 mg/day for zinc and 400 mcg/day for selenium, and too much selenium can itself cause hair loss.[8][9] Biotin can distort some lab tests; see Biotin & Hair Loss Lab Tests and Zinc Deficiency & Hair Loss. Take them only with your prescriber’s advice and after labs show a need.
  5. Handle hair gently: reduce heat and tight styles while shedding, but expect this to protect existing hair rather than stop the shedding.
  6. Track monthly: photos every 4 weeks (same angle and lighting) to judge the trend, not daily anxiety.

When to see a doctor

  • Scalp pain/burning, pustules, open sores, heavy scale/crusting
  • Patchy smooth bald spots
  • Shedding persisting beyond ~6 months or recurrent waves[5]
  • New facial hair growth, irregular periods, or acne alongside the hair loss
  • Any thought of stopping the medication because of hair loss: speak to the prescriber first

Start here: When to See a Doctor.


FAQ

Does Depakote cause hair loss?

Yes, it is a recognized adverse reaction. The US label reports alopecia in its trials and lists it among the most common adverse reactions, and the UK information classes it as common.[1][6] Most people do not lose hair, and the rate depends on the condition and dose studied.

How common is it?

Label rates range from 6% to 7% versus 1% on placebo in add-on and migraine trials, up to 24% at higher doses in the epilepsy monotherapy trial.[1] A pooled analysis estimated about 11% overall.[7] The sources do not give a reliable figure for adolescent girls, men, or older adults specifically.

When does the hair loss start?

Usually about 3 to 6 months after starting the drug or raising the dose.[3] This delay is why many people do not connect the two.

Is Depakote hair loss permanent or reversible?

It is typically non-scarring and usually reversible, though regrowth can be incomplete and slow.[3] The UK information says regrowth normally begins within six months.[6] I did not find evidence that long-term use makes the loss permanent, and if thinning persists, reassess for overlapping pattern hair loss.

Will my hair grow back if I stay on it?

Often the shedding eases over months, but the sources do not quantify regrowth for people who continue treatment. Ask your prescriber what to expect in your case.

Will my hair come back if I stop Depakote?

Regrowth within a few months of stopping a causative drug is described, but stopping should be a medical decision, not a hair decision. Valproate protects against seizures and mood episodes in many people, and stopping suddenly can cause serious problems.[1]

Does a higher dose increase the risk?

Possibly: the label’s high-dose group had more alopecia than the low-dose group, but a pooled analysis found no dose effect.[1][7] There is no reliable evidence for a specific milligram threshold, or for differences between extended-release and delayed-release tablets.

Can Depakote change hair texture or color?

The US label lists hair texture and hair color changes in postmarketing reports. The UK information says regrown hair may be more curly than before.[1][6]

What supplement should I take?

None is proven. Zinc, selenium and biotin are discussed in isolated case reports, and the review calls the evidence low-level.[3] Get labs and your prescriber’s advice first, and respect upper limits.[8][9]

Why am I growing chin or facial hair on Depakote?

Hirsutism and hyperandrogenism appear in valproate labeling as reported effects.[1][6] Mention it to your doctor, especially with irregular periods or acne.

Is lithium or Depakote worse for hair?

Both are associated with hair loss, and published estimates vary widely between studies, so no safe ranking can be given here. If hair loss is bothering you, discuss options with your prescriber.


References (trusted sources)

  1. DailyMed: Depakote (divalproex sodium) delayed-release tablets, FDA prescribing information (revised 3/2026)
  2. NCBI Bookshelf (StatPearls): Valproic Acid — adverse effects include alopecia
  3. Pitton Rissardo et al. (2023), Medicines: Antiseizure Medication-Induced Alopecia: A Literature Review
  4. DermNet NZ: Telogen effluvium (hair fall noticed 2–4 months after trigger)
  5. British Association of Dermatologists (Skin Health Info): Telogen effluvium (around 3 months after a trigger)
  6. UK electronic medicines compendium: Epilim Chrono (sodium valproate) SmPC — alopecia frequency and regrowth
  7. Wang et al. (2019), Seizure 69:61–69: meta-analysis of alopecia incidence with valproate
  8. NIH Office of Dietary Supplements: Zinc (health professional fact sheet)
  9. NIH Office of Dietary Supplements: Selenium (health professional fact sheet)

TOUATI

I have lived with hair loss since 2019. After consulting several doctors and researching every day, I founded Hair Health Blog to share clear, evidence-based answers with people facing the same problem. Not a doctor; always consult a dermatologist.facebook instagram

Previous Post Next Post

Contact Form